Dexcel Pharma Technologies Ltd.
USPTO PatentsView assignee record - 15 granted patents across 4 technology areas, recorded in grant years 2016–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Dexcel ranks #18,534 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 4 technology areas.
- #18,534
- of 49,997 US assignees by volume
- 35th percentile
- by Innovation Score (30.6/100)
- 19.1
- avg claims per patent
- +100%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18534 · Foreign Corporation #18,534 · 15 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 15 grants
- MID-PACK #18,534/49,997
- PHOTO-FINISH Dankook University…
- CPC-NARROW A61K · 4 areas
- INNOV-THIN 30.6/100
- CLAIMS-RICH 19.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +100% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Dankook University Cheonan Campus Industry Academic Cooperation Foundation (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Dexcel’s 30.6 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Dexcel
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Dexcel Pharma · this assignee 31
Dexcel Pharma · this assignee
31 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Dexcel's Innovation Score is 30.6/100 (35th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Dexcel?
Each dot is one of Dexcel’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dexcel’s own 19.1 claims/patent is ABOVE the 13.3 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Dexcel's grants concentrate
Dexcel Pharma Technologies Ltd. is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2016. By volume, Dexcel sits between Dankook University Cheonan Campus Industry Academic Cooperation Foundation and Dish Network Corporation.
Dexcel's three-year grant acceleration
Dexcel Pharma Technologies Ltd. shows 3 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Dexcel's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Dankook Universit…
Dankook University Cheonan Campus Industry Academic Cooperation Foundation
15 patents
- DCG Systems
DCG Systems, Inc.
15 patents
- Decision Sciences…
Decision Sciences Medical Company, LLC
15 patents
- Delsey
Delsey
15 patents
- Dialpad
Dialpad, Inc.
15 patents
- DIC (Tokyo)
DIC Corporation (TOKYO)
15 patents
- Dipharma Francis…
Dipharma Francis S.R.L.
15 patents
- Dish Network
Dish Network Corporation
15 patents
- Dexcel Pharma ◀
Dexcel Pharma Technologies Ltd.
15 patents
What this shows Dexcel holds 15 patents at rank #18,527, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dexcel
By rank, the assignees closest to #18,527 in granted patent volume.
- Dankook University Cheonan Campus Industry Academic Cooperation Foundation #18,523 · 15 patents
- DCG Systems, Inc. #18,524 · 15 patents
- Decision Sciences Medical Company, LLC #18,525 · 15 patents
- Delsey #18,526 · 15 patents
- Dialpad, Inc. #18,528 · 15 patents
- DIC Corporation (TOKYO) #18,529 · 15 patents
- Dipharma Francis S.R.L. #18,530 · 15 patents
- Dish Network Corporation #18,531 · 15 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Dexcel's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Dexcel's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
31 35th percentile higher than 35% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 6.7% |
| 2017 | 1 | 6.7% |
| 2018 | 2 | 13.3% |
| 2019 | 1 | 6.7% |
| 2020 | 4 | 26.7% |
| 2021 | 3 | 20.0% |
| 2022 | 2 | 13.3% |
| 2024 | 1 | 6.7% |
Which technologies does Dexcel Pharma Technologies Ltd. patent most?
Top 4 of 4 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Dexcel Pharma Technologies Ltd.'s patent record in context - here's where to go next.
- Dexcel Pharma Technologies Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #18,534 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Dexcel Pharma Technologies Ltd. against Dankook University Cheonan Campus Industry Academic Cooperation Foundation, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.